Brilliant Violet 421TM anti-STAT3 Phospho (Tyr705) [13A3-1]

BioLegend Inc. was awarded contract A207_PO-0452601 by the University of Virginia on June 25, 2026, for the supply of laboratory reagents. The prime contractor will deliver one unit of Brilliant Violet 421™ anti-STAT3 Phospho (Tyr705) [13A3-1], a fluorescently-labeled monoclonal antibody used for flow cytometry applications in research settings. The contract value totals $309.75, with delivery designated to Ashlyn Cowan at the University of Virginia.

This procurement represents a straightforward materials purchase executed through the University of Virginia's procurement process within the Commonwealth of Virginia. The specified product is a single-use research reagent commonly employed in immunological and cell biology studies for detecting phosphorylated Signal Transducer and Activator of Transcription 3 (STAT3) protein. No specific performance period, delivery date, or place of performance beyond the identified recipient is detailed in the available contract documentation.